Werkgroep Cardiologische centra Nederland

TRUE AHF (Completed)

Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Ularitide (Urodilatin) Intravenous Infusion in Patients Suffering from Acute Decompensated Heart Failure
Medicine
Urodilatin (Ularitide)
Population
Heart failure
Phase
III
Starting year
2012
More information
ClinicalTrials.gov

Director of Study

drs. F.R. den Hartog (Cardioloog)
Ede, Gelderse Vallei Ziekenhuis

TRUE AHF: News